Altimmune, Inc. (ALT)
2.05
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 09:36
Altimmune Price : 2.05 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 2.13 | 2.15 | 2.02 | 2.05 | 3.499M |
| Oct 23, 2026 | 2.16 | 2.20 | 2.06 | 2.12 | 2.600M |
| Oct 22, 2026 | 2.20 | 2.245 | 2.15 | 2.17 | 3.094M |
| Oct 21, 2026 | 2.31 | 2.35 | 2.19 | 2.23 | 4.502M |
| Oct 20, 2026 | 2.22 | 2.32 | 2.20 | 2.30 | 2.306M |
| Oct 19, 2026 | 2.22 | 2.26 | 2.18 | 2.23 | 2.611M |
| Oct 16, 2026 | 2.365 | 2.369 | 2.17 | 2.20 | 4.243M |
| Oct 15, 2026 | 2.31 | 2.38 | 2.29 | 2.36 | 3.354M |
| Oct 14, 2026 | 2.40 | 2.41 | 2.29 | 2.31 | 5.627M |
| Oct 13, 2026 | 2.56 | 2.56 | 2.43 | 2.43 | 3.718M |
| Oct 12, 2026 | 2.59 | 2.625 | 2.56 | 2.56 | 2.160M |
| Oct 09, 2026 | 2.60 | 2.64 | 2.57 | 2.61 | 2.678M |
| Oct 08, 2026 | 2.66 | 2.66 | 2.55 | 2.60 | 4.931M |
| Oct 07, 2026 | 2.64 | 2.74 | 2.63 | 2.66 | 3.168M |
| Oct 06, 2026 | 2.70 | 2.70 | 2.64 | 2.67 | 7.627M |
| Oct 05, 2026 | 2.73 | 2.747 | 2.65 | 2.67 | 3.840M |
| Oct 02, 2026 | 2.80 | 2.81 | 2.71 | 2.735 | 4.253M |
| Oct 01, 2026 | 2.85 | 2.85 | 2.75 | 2.76 | 3.594M |
| Sep 30, 2026 | 2.99 | 2.99 | 2.86 | 2.86 | 4.922M |
| Sep 29, 2026 | 2.99 | 3.006 | 2.92 | 2.97 | 2.564M |
| Sep 28, 2026 | 3.04 | 3.07 | 2.95 | 2.96 | 3.360M |
| Sep 25, 2026 | 3.05 | 3.11 | 3.00 | 3.06 | 2.859M |
| Sep 24, 2026 | 3.18 | 3.20 | 2.98 | 3.04 | 3.686M |
| Sep 23, 2026 | 3.42 | 3.425 | 3.15 | 3.19 | 4.532M |
| Sep 22, 2026 | 3.33 | 3.41 | 3.25 | 3.41 | 4.003M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Protalix Biotherapeutics, Inc. | 2.48 |
| Taysha Gene Therapies, Inc. | 3.97 |
| Humacyte, Inc. | 0.4101 |
| Liquidia Corp. | 43.97 |
| Agenus, Inc. | 6.185 |
Price Related Metrics
| PS Ratio | 8265.09 |
| Price to Book Value | 0.8407 |
| Earnings Yield | -38.48% |
| Market Cap | 398.67M |